Evaluation of eribulin and bevacizumab for the real world treatment of recurrent breast cancer

被引：0
|
作者：
Earashi, M. [1 ]
Matsui, K. [2 ]
Maeda, K. [2 ]
Fukushima, W. [3 ]
Shimada, K. [4 ]
Shimizu, T. [5 ]
Nozaki, Z. [6 ]
Tanada, Y. [6 ]
Oyama, K. [7 ]
Nagata, T. [8 ]
Tsuneda, A. [9 ]
Yoshikawa, A. [10 ]
Yoshida, T. [11 ]
Kiyohara, K. [12 ]
Iwata, K. [13 ]
Ii, T. [14 ]
机构：
[1] Yatsuo Gen Hosp, Dept Breast Suegery, Toyama, Japan
[2] Toyama Prefectural Cent Hosp, Depertment Surg, Toyama, Japan
[3] Takaoka City Hosp, Derartment Surg, Takaoka, Toyama, Japan
[4] Imizu Municipal Hosp, Dept Surg, Imizu, Toyama, Japan
[5] Saiseikai Toyama Hosp, Dept Surg, Toyama, Japan
[6] Toyama Red Cross Hosp, Dept Surg, Toyama, Japan
[7] Kouseiren Takaoka Hosp, Dept Surg, Takaoka, Toyama, Japan
[8] Toyama Univ Hosp, Dept Surg, Toyama, Japan
[9] Toyama Rosai Hosp, Dept Surg, Uozu, Toyama, Japan
[10] Toyama City Hosp, Dept Surg, Toyama, Japan
[11] Saiseikai Takaoka Hosp, Dept Surg, Takaoka, Toyama, Japan
[12] Tonami Gen Hosp, Dept Surg, Tonami, Toyama, Japan
[13] Kurobe City Hosp, Dept Surg, Kurobe, Japan
[14] Kouseiren Namerikawa Hosp, Dept Surg, Namerikawa, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
110P
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [41] BEVACIZUMAB FOR BREAST CANCER: SCIENTIFIC EVIDENCE VERSUS REAL WORLD DATA (RWD) IN BRAZIL
    Feijo, L.
    Pegoretti Rosa, B.
    Moraes, Z.
    Goes, L.
    Clark, L. G.
    VALUE IN HEALTH, 2017, 20 (09) : A881 - A881
  • [42] Bevacizumab Treatment for Metastatic Colorectal Cancer in Real-World Clinical Practice
    Dinu, Ioana Mihaela
    Mihaila, Mariana
    Diculescu, Mircea Mihai
    Croitoru, Vlad Mihai
    Turcu-Stiolica, Adina
    Bogdan, Diana
    Miron, Monica Ionela
    Lungulescu, Cristian Virgil
    Alexandrescu, Sorin Tiberiu
    Dumitrascu, Traian
    Buica, Florina
    Luca, Ioana Niculina
    Lungulescu, Cristina
    Negulescu, Madalina Cristina
    Gramaticu, Iulia Magdalena
    Cazacu, Irina Mihaela
    Croitoru, Adina Emilia
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [43] Bevacizumab in the Treatment of Metastatic Breast Cancer Bevacizumab in Breast Cancer: The Best Is Yet to Come?
    Traina, Tiffany A.
    ONCOLOGY-NEW YORK, 2009, 23 (04): : 327 - 332
  • [44] Treatment Strategy and Safety of Eribulin in Advanced Breast Cancer
    Wang, Xinli
    Liu, Shusong
    Xue, Yan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (01): : 122 - 124
  • [45] Bevacizumab in Neoadjuvant Treatment for Breast Cancer
    Miklos, George L. Gabor
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (17): : 1638 - 1638
  • [46] Bevacizumab Treatment for Advanced Breast Cancer
    Alvarez, Ricardo H.
    Guarneri, Valentina
    Icli, Fikri
    Johnston, Stephen
    Khayat, David
    Loibl, Sibylle
    Martin, Miguel
    Zielinski, Christoph
    Conte, PierFranco
    Hortobagyi, Gabriel N.
    ONCOLOGIST, 2011, 16 (12): : 1684 - 1697
  • [47] Bevacizumab in the treatment of metastatic breast cancer
    Schuetz, Florian
    Sohn, Christof
    Schneeweiss, Andreas
    BREAST CARE, 2007, 2 (02) : 82 - 88
  • [48] Real-world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer
    Qian, Xiaoyan
    Tao, Yunxia
    Chen, Haizhu
    Li, Xin
    Wang, Yaqin
    Xu, Xiaoming
    Li, Shuo
    Chen, Haoyu
    Cang, Shundong
    Liu, Yang
    ONCOLOGY LETTERS, 2025, 29 (01)
  • [49] Real-world treatment patterns and clinical effectiveness outcomes of eribulin in metastatic breast cancer patients in community oncology centers in the United States
    Mougalian, S. S.
    Kish, J. K.
    Zhang, J.
    Miller, T.
    Liassou, D.
    Laney, J.
    Iyer, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S369 - S369
  • [50] Real-world experience with trabectedin for the treatment of recurrent ovarian cancer
    Romero, Ignacio
    Lopez-Guerrero, Jose Antonio
    Pignata, Sandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (10) : 1089 - 1095
12345